Refreshing results…
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3
UploadA rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent
UploadMissing publications? Search for publications with a matching author name.